Today, artificial intelligence (AI) and big data are rapidly revolutionising every industry, including the biotechnology sector. These cutting-edge technologies are driving innovation and transformation, leading to the development of novel therapeutics, personalised medicine, and improved healthcare outcomes. In this blog post, we explore the transformative impact of big data and
Are biotech advancements reshaping healthcare by directly targeting the core processes of ageing, promising longevity and a bolstered state of health? In a recent interview, Herna De Wit, Head of Bioscience at Human Edge, talked with Muhammad Younis about the interplay of these variables, and the future that lies on
Glasgow, UK, 14 Nov, 2023: Glox Therapeutics, the company at the forefront of crafting precise antibiotic treatments derived from natural bacteriocins, has secured £4.3 million in initial funding. This funding aims to drive the development of highly targeted therapies aimed specifically at combating antibiotic-resistant Gram-negative bacteria. The company plans
Bioagro, a facet of Biotechnology, presents a compelling alternative to traditional chemical farming practices. In a recent interview, Sheldon Caref, President at BioAgro Science for Life, discussed with Muhammad Younis the ecological and health implications associated with conventional chemical methods in farming, and how BioAgro emerges as a game-changing solution.
In a recent interview, Pierre Cressard, Co-founder and CEO of Nahibu, a global microbiome company, talked with Muhammad Younis about the pivotal role of the microbiome in shaping the overall health of living beings, while also delving into the significant contributions made by Nahibu in this field #LBS: What role